UPDATE: Stifel Nicolaus Initiates Henry Schein at Hold on Valuation
Stifel Nicolaus initiated coverage on Henry Schein (NASDAQ: HSIC) with a Hold rating.
Stifel Nicolaus commented, "Henry Schein's market share gains in N.A. dental and veterinary have outpaced that of Patterson, the company's biggest competitor. As a result, we believe Schein's premium valuation is well deserved. That said, for the stock to post 20% upside from current levels, Henry Schein would need to recapture a 20x NTM EPS multiple. The stock's peak multiple over the past three years is in the high teens."
Henry Schein closed at $82.23 on Wednesday.
Latest Ratings for HSIC
|Jul 2015||Evercore Partners||Downgrades||Buy||Hold|
|Jun 2015||RBC Capital||Initiates Coverage on||Outperform|
|Nov 2014||Credit Suisse||Maintains||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.